Cargando…

PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway

Increasing evidence suggest that pleckstrin-2 (PLEK2) acts as an oncogene in several malignancies. The present study aimed to investigate the effects of PLEK2 on osteosarcoma (OS) tumorigenesis and metastasis. PLEK2 expression in OS was analyzed via bioinformatics, reverse transcription-quantitative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Yang, Siting, Wang, Feng, Zhou, Zheng, Xu, Wenjing, Xie, Jingjing, Qiao, Linhui, Gu, Yanglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161470/ https://www.ncbi.nlm.nih.gov/pubmed/34084215 http://dx.doi.org/10.3892/ol.2021.12795

Ejemplares similares

TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis
por: Zhao, Guo-sheng, et al.
Publicado: (2018)

PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway
por: Shen, Hui, et al.
Publicado: (2019)

Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway
por: Xu, Chaojian, et al.
Publicado: (2022)

Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021)

PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop
por: Zhao, Xinyuan, et al.
Publicado: (2022)

TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2
por: Wang, Feng, et al.
Publicado: (2021)

Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway
por: Yu, Guangyang, et al.
Publicado: (2018)

CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway
por: Chen, Houping, et al.
Publicado: (2021)

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
por: Xiang, Yubo, et al.
Publicado: (2023)

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
por: Cui, Yong, et al.
Publicado: (2022)

Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
por: Zhu, Hui-er, et al.
Publicado: (2019)

Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis
por: Zhao, Man, et al.
Publicado: (2023)

NLRP6 potentiates PI3K/AKT signalling by promoting autophagic degradation of p85α to drive tumorigenesis
por: Zhi, Feng, et al.
Publicado: (2023)

TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling
por: Liu, Wenxiu, et al.
Publicado: (2021)

Retraction: APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway
Publicado: (2019)

Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway
por: Zhang, Dong, et al.
Publicado: (2017)

Upregulation of the PI3K/Akt Pathway in the Tumorigenesis of Canine Thyroid Carcinoma
por: Campos, M., et al.
Publicado: (2014)

Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling
por: Doppelt-Flikshtain, Ofri, et al.
Publicado: (2023)

KIF21B Expression in Osteosarcoma and Its Regulatory Effect on Osteosarcoma Cell Proliferation and Apoptosis Through the PI3K/AKT Pathway
por: Ni, Songjia, et al.
Publicado: (2021)

PLEK: a tool for predicting long non-coding RNAs and messenger RNAs based on an improved k-mer scheme
por: Li, Aimin, et al.
Publicado: (2014)

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor
por: Peng, Daohu, et al.
Publicado: (2021)

[Retracted] SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling
por: Wang, Hanning, et al.
Publicado: (2023)

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling
por: Tong, Qing, et al.
Publicado: (2023)

PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis
por: Xu, Wenting, et al.
Publicado: (2018)

Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis
por: Yang, Bingsheng, et al.
Publicado: (2021)

RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway
por: Hua, Hao, et al.
Publicado: (2023)

DPY30 promotes the growth and survival of osteosarcoma cells by regulating the PI3K/AKT signal pathway
por: Cheng, Gong, et al.
Publicado: (2022)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
por: Jiang, Liang, et al.
Publicado: (2017)

Schisandrin B suppresses osteosarcoma lung metastasis in vivo by inhibiting the activation of the Wnt/β-catenin and PI3K/Akt signaling pathways
por: Wang, Yuping, et al.
Publicado: (2022)

Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling
por: Yang, Juan, et al.
Publicado: (2020)

Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways
por: Li, Xiucheng, et al.
Publicado: (2017)

SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway
por: Zhu, Bin, et al.
Publicado: (2017)

Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway
por: Zhang, Yong, et al.
Publicado: (2020)

β-Escin inhibits the proliferation of osteosarcoma cells via blocking the PI3K/Akt pathway
por: Zhu, Minyu, et al.
Publicado: (2018)

Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway
por: Yu, Huiqing, et al.
Publicado: (2021)

TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation
por: Ma, Kun, et al.
Publicado: (2020)

HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway
por: Ma, Kun, et al.
Publicado: (2022)

Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways
por: Cheng, Shengwen, et al.
Publicado: (2023)

EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway
por: Wang, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_amo7q98p1ug3k9isr1n5l3hc3f